Institute of Transplantation, The Freeman Hospital, Newcastle upon Tyne, UK.
Cochrane Database Syst Rev. 2023 Jul 14;7(7):CD013788. doi: 10.1002/14651858.CD013788.pub2.
The optimal treatment for end-stage kidney disease is kidney transplantation. During the operation, a catheter is introduced into the bladder and remains in place postoperatively to allow the bladder to drain. This decreases tension from the cysto-ureteric anastomosis and promotes healing. Unfortunately, urinary catheters can pose an infection risk to patients as they allow bacteria into the bladder, potentially resulting in a urinary tract infection (UTI). The longer the catheter remains in place, the greater the risk of developing a UTI. There is no consensus approach to the time a catheter should remain in place post-transplant. Furthermore, the different timings of catheter removal are thought to be associated with different incidences of UTI and postoperative complications, such as anastomotic breakdown.
This review aimed to compare patients who had their catheter removed < 5 days post-transplant surgery to those patients who had their catheter removed ≥ 5 days following their kidney transplant. Primary outcome measures between the two groups included: the incidence of symptomatic UTIs, the incidence of asymptomatic bacteriuria and the incidence of major urological complications requiring intervention and treatment.
We searched the Cochrane Kidney and Transplant Register of Studies up to 13 April 2023 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Registry Platform (ICTRP) Search Portal and ClinicalTrials.gov.
All randomised controlled trials (RCTs) and quasi-RCTs comparing timing of catheter removal post-transplantation were eligible for inclusion. All donor types were included, and all recipients were included regardless of age, demographics or type of urinary catheter used.
Results from the literature search were screened by two authors to identify if they met our inclusion criteria. We designated removal of a urinary catheter before five days (120 hours) as an 'early removal' and anything later than this as a 'late removal.' The studies were assessed for quality using the risk of bias tool. The primary outcome of interest was the incidence of asymptomatic bacteriuria. Statistical analyses were performed using the random effects model, and results were expressed as relative risk (RR) with 95% confidence intervals (CI). Confidence in the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
Two studies (197 patients) were included in our analysis. One study comprised a full-text article, and the other was a conference abstract with very limited information. The risk of bias in the included studies was generally either high or unclear. It is uncertain whether early versus late removal of the urinary catheter made any difference to the incidence of asymptomatic bacteriuria (RR 0.89, 95% Cl 0.17 to 4.57; participants = 197; I = 88%; very low certainty evidence). Data on other outcomes, such as the incidence of UTI and the incidence of major urological complications, were lacking. Furthermore, the follow-up of patients across the studies was short, with no patients being followed beyond one month.
AUTHORS' CONCLUSIONS: A high-quality, well-designed RCT is required to compare the effectiveness of early catheter removal versus late catheter removal in patients following a kidney transplant. At the present time, there is insufficient evidence to suggest any difference between early and late catheter removal post-transplant, and the studies investigating this were generally of poor quality.
终末期肾病的最佳治疗方法是肾移植。在手术过程中,将导管插入膀胱并在术后保留在原位,以使膀胱排空。这可以减少膀胱输尿管吻合口的张力,促进愈合。不幸的是,由于导尿管允许细菌进入膀胱,可能导致尿路感染(UTI),因此会给患者带来感染风险。导尿管保留的时间越长,发生 UTI 的风险就越大。对于移植后应保留导尿管的时间,尚无共识方法。此外,导管移除的不同时间被认为与不同的 UTI 发生率和术后并发症(例如吻合口破裂)有关。
本综述旨在比较在移植手术后<5 天内将导管取出的患者与在肾移植后≥5 天取出导管的患者。两组之间的主要结局测量指标包括:有症状 UTI 的发生率,无症状菌尿的发生率以及需要干预和治疗的主要泌尿道并发症的发生率。
我们通过与信息专家联系,使用与本综述相关的搜索词,在 2023 年 4 月 13 日之前对 Cochrane 肾脏和移植登记处的研究进行了搜索。通过搜索 CENTRAL、MEDLINE 和 EMBASE、会议论文集、国际临床试验注册平台(ICTRP)搜索门户和 ClinicalTrials.gov,确定登记处中的研究。
所有随机对照试验(RCT)和准 RCT 都符合纳入标准,比较了移植后导管取出的时间。所有供体类型均包括在内,无论年龄、人口统计学特征或使用的导尿管类型如何,所有接受者都包括在内。
通过两名作者筛选文献搜索结果,以确定它们是否符合我们的纳入标准。我们将导尿管在 5 天(120 小时)之前的移除指定为“早期移除”,而任何晚于此时间的移除则为“晚期移除”。使用偏倚风险工具评估研究的质量。主要研究结果为无症状菌尿的发生率。使用随机效应模型进行了统计分析,并使用 95%置信区间(CI)表示相对风险(RR)。使用推荐评估、制定与评估(GRADE)方法评估证据的可信度。
我们的分析纳入了两项研究(197 名患者)。一项研究包括一篇全文文章,另一项是会议摘要,信息量非常有限。纳入研究的偏倚风险通常较高或不明确。不确定早期与晚期去除导尿管对无症状菌尿的发生率有何影响(RR 0.89,95%CI 0.17 至 4.57;参与者=197;I = 88%;非常低确定性证据)。缺乏其他结局的数据,例如 UTI 发生率和主要泌尿道并发症的发生率。此外,研究对患者的随访时间较短,没有患者的随访时间超过一个月。
需要一项高质量、精心设计的 RCT 来比较肾移植后早期导管去除与晚期导管去除的有效性。目前,没有足够的证据表明早期和晚期导管去除之间存在任何差异,并且研究这个问题的研究通常质量较差。